In conjunction with Pharmaceutical Commerce, Acsis recently surveyed manufacturers to capture serialization progress, challenges and expected benefits of going “beyond” Drug Supply Chain Security Act (DSCSA) compliance.
Join subject matter experts from AmerisourceBergen, Excellis Healthcare and Acsis as we discuss the next phase of the DSCSA requirements, with a focus on warehousing and distribution.
If you’re like most manufacturers today, your world includes a diverse group of partners, such as subcontractors, co-manufacturers and third-party distributors. But what it do…Read More >>
IDC recently published its MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor Assessment, which named Acsis as a Major Player. The key selection criteria…Read More >>
Looking for guidance on DSCSA compliance and the benefits of serialization? Then you are in luck. We recently published a white paper (download it here) that explores the value …Read More >>